In Association With ILC Dover

Powder Handling

Partner Content

Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing

Partner Content

Chemical synthesis: containment challenges for HPAPI handling

Partner Content

How API CMOs can improve containment capabilities without facility acquisition

Partner Content

The future of the gene therapy market: driving innovations in biotherapeutics

Partner Content

Protecting the supply chain: Why biopharma needs integrated workflows

Partner Content

Powered air-purifying respirators: a necessity for small molecule API manufacturing

Partner Content

How isolators can cut cleaning measures with contamination-free disposal

Partner Content

Maximise profits while minimising product loss with 3D powder handling

Partner Content

Eliminating product variants and risk in pharmaceutical development

Partner Content

Solutions for handling nanogram level potent products to pass containment testing

Partner Content

Meeting the demand for potent product handling in a sterile environment

Partner Content

How containment systems impact productivity and profitability for HPAPI development

Partner Content

The DoverPac story: what increased HPAPI usage means for containment systems

Partner Content

Single-use isolation technology for safe handling of oxygen sensitive materials

Partner Content

Creating a disposable aseptic isolation system

Partner Content

Is a hooded PAPR right for your organisation?

Partner Content

The right transfer solutions for media and buffer powders

Partner Content

Flexible Isolator Technology: The Containment Solution for Pharmaceutical Processing

Partner Content

How single-use FIBC containment systems can work for you

Partner Content

High containment for lyophilisation processes

Partner Content

The benefits of single-use plastics versus reusable systems in upstream processes

Partner Content

To clean or not to clean? Why single use is better for pharma HPAPI containment

Partner Content

How CMO/CDMO facilities can gain value with single use containment

Partner Content

HPAPI: Dealing with containment challenges

Partner Content

How “just in time” hydration of cell culture media can be optimised by single-use powder handling

Partner Content

Transforming preparation processes with the EZ BioPac transfer bag

Partner Content

ILC Dover’s new Cork manufacturing plant includes 10,500 sq ft of clean room capability

Partner Content

What is biomanufacturing?

Partner Content

The environmental benefits of single-use pharmaceutical containment plastics

Partner Content

Learn how the innovations from Space Suits are applied in modern drug manufacturing

Partner Content

The challenges of scaling up pharmaceutical manufacturing

Partner Content

ILC Dover’s JetMixer: an efficient method of liquefying powders

Partner Content

How to prevent contamination in a biopharmaceutical manufacturing operation

Partner Content

Should pharmaceutical manufacturers invest in single-use containment?

Partner Content

Flexible powder containment: ILC Dover’s DoverPac system

Partner Content

Effective containment systems for high potency active pharmaceutical ingredients (HP APIs)

Partner Content

Reduce cross-contamination risk with single-use isolator technology

Partner Content

How CMOs can benefit from single-use solutions

Latest

Partner Content

Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing

Partner Content

Chemical synthesis: containment challenges for HPAPI handling

Partner Content

How API CMOs can improve containment capabilities without facility acquisition

Partner Content

The future of the gene therapy market: driving innovations in biotherapeutics

Latest White Papers

Five major cybersecurity challenges all connected organisations need to know about